Association between IL-6 and metabolic syndrome in schizophrenia patients treated with second-generation antipsychotics

OBJECTIVE: Second-generation antipsychotics (SGAs) have a high risk of causing metabolic syndrome (MetS). There is accumulating evidence supporting the fact that the activation of inflammatory pathway contributes to the development of MetS and further aggravates cognitive impairment. This study aime...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Xinyu, Wang, Yewei, Chen, Yan, Ren, Juanjuan, Zhang, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681158/
https://www.ncbi.nlm.nih.gov/pubmed/31534339
http://dx.doi.org/10.2147/NDT.S202159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681158/
https://www.ncbi.nlm.nih.gov/pubmed/31534339
http://dx.doi.org/10.2147/NDT.S202159

Ejemplares similares